Assessing Perceptions and Preferences around Long-acting Injectables
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Review of challenges, facilitators, and best practices for routine screening, linkage, and rapid ART in two emergency departments, including during COVID-19.
Resource (Conference Presentation) updated 09/14/2023
Outline of an approach to HIV pre-exposure prophylaxis (PrEP) in health centers that incorporates and builds upon the strengths of medical and behavioral health clinicians.
Resource (Conference Presentation) updated 09/14/2023
Resource updated 10/24/2023
Resource updated 05/11/2023
Resource updated 05/11/2023
Resource updated 12/19/2023
Resource updated 10/18/2023
Resource updated 05/10/2023
Resource from the RWHAP Best Practices Compilation updated on 05/14/2024
Resource from the RWHAP Best Practices Compilation updated on 11/13/2023
Resource updated 09/19/2023
Resource updated 05/08/2024
Resource updated 04/03/2024
Resource updated 04/03/2024
In a single-center restrospective cohort study, patients with extensive treatment experience and history of virologic failure and multi-drug resistance underwent simplification of ARV salvage regimens with a median pill burden reduction of six pills per day. This strategy led to high rates of virologic suppression.
Resource (Conference Presentation) updated 09/14/2023
The first long-acting injectable antiretroviral therapy (LAI ART) formulation was FDA-approved January 2021. Drawing on the Consolidated Framework on Implementation Research, this mixed methods study assessed knowledge, attitudes, practices, and perceived barriers and facilitators related to implementation of LAI ART in NYC among HIV clinic staff and people with HIV.
Resource (Conference Presentation) updated 09/14/2023